Filing Details
- Accession Number:
- 0001209191-11-023607
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-04-20 11:37:31
- Reporting Period:
- 2011-04-18
- Filing Date:
- 2011-04-20
- Accepted Time:
- 2011-04-20 11:37:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1367644 | Emergent Biosolutions Inc. | EBS | Pharmaceutical Preparations (2834) | 141902018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1380895 | Intervac, L.l.c. | C/O East-West Resources Corporation 12001 Glen Road Potomac MD 20854 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-04-18 | 7,000 | $23.31 | 6,136,794 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This price is the weighted average sale price for the transaction reported on this line. The prices for this transaction range from $23.01 to $24.00. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2011.
Billionaire Hedge Funds
